# EDGEWELL PERSONAL CARE Co: financial statements, quarterly

EPC · NYSE · CIK 1096752 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/epc.md) · [Financials](/companies/epc/financials.md) · [Filings](/companies/epc/filings.md) · [Insiders](/companies/epc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/epc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [534](/filings/0001628280-23-040139.md) | [489](/filings/0001628280-25-004522.md) | [599](/filings/0001628280-25-023206.md) | [648](/filings/0001628280-25-037827.md) | [518 d](/filings/0001628280-25-052765.md) | [415](/filings/0001628280-26-006288.md) | [517](/filings/0001628280-26-031376.md) | [560](/filings/0001628280-26-053128.md) | [731 d](/filings/0001628280-25-052765.md) | [423](/filings/0001628280-26-006288.md) | [520](/filings/0001628280-26-031376.md) | [570](/filings/0001628280-26-053128.md) |
| Cost of revenue | $m | [306 d](/filings/0001628280-25-052765.md) | [291](/filings/0001628280-25-004522.md) | [341](/filings/0001628280-25-023206.md) | [361](/filings/0001628280-25-037827.md) | [305 d](/filings/0001628280-25-052765.md) | [243](/filings/0001628280-26-006288.md) | [280](/filings/0001628280-26-031376.md) | [310](/filings/0001628280-26-053128.md) | [466 d](/filings/0001628280-25-052765.md) | [262](/filings/0001628280-26-006288.md) | [303](/filings/0001628280-26-031376.md) | [328](/filings/0001628280-26-053128.md) |
| Gross profit | $m | [229](/filings/0001628280-23-040139.md) | [198](/filings/0001628280-25-004522.md) | [258](/filings/0001628280-25-023206.md) | [287](/filings/0001628280-25-037827.md) | [213 d](/filings/0001628280-25-052765.md) | [173](/filings/0001628280-26-006288.md) | [237](/filings/0001628280-26-031376.md) | [250](/filings/0001628280-26-053128.md) | [266 d](/filings/0001628280-25-052765.md) | [161](/filings/0001628280-26-006288.md) | [217](/filings/0001628280-26-031376.md) | [243](/filings/0001628280-26-053128.md) |
| Research and development | $m | [15.9 d](/filings/0001628280-25-052765.md) | [13.3](/filings/0001628280-25-004522.md) | [14.2](/filings/0001628280-25-023206.md) | [14.6](/filings/0001628280-25-037827.md) | [16.3 d](/filings/0001628280-25-052765.md) | [13.4](/filings/0001628280-26-006288.md) | [13.4](/filings/0001628280-26-031376.md) | [13.5](/filings/0001628280-26-053128.md) | [17.4 d](/filings/0001628280-25-052765.md) | [13.8](/filings/0001628280-26-006288.md) | [14.9](/filings/0001628280-26-031376.md) | [13.3](/filings/0001628280-26-053128.md) |
| Selling, general and administrative | $m | [112 d](/filings/0001628280-25-052765.md) | [103](/filings/0001628280-25-004522.md) | [108](/filings/0001628280-25-023206.md) | [110](/filings/0001628280-25-037827.md) | [109 d](/filings/0001628280-25-052765.md) | [99.6](/filings/0001628280-26-006288.md) | [103](/filings/0001628280-26-031376.md) | [101](/filings/0001628280-26-053128.md) | [122 d](/filings/0001628280-25-052765.md) | [102](/filings/0001628280-26-006288.md) | [111](/filings/0001628280-26-031376.md) | [108](/filings/0001628280-26-053128.md) |
| Operating income | $m | [52.1 d](/filings/0001628280-25-052765.md) | [26.1](/filings/0001628280-25-004522.md) | [70.1](/filings/0001628280-25-023206.md) | [82.7](/filings/0001628280-25-037827.md) | [20.4 d](/filings/0001628280-25-052765.md) | [9.3](/filings/0001628280-26-006288.md) | [49.0](/filings/0001628280-26-031376.md) | [45.0](/filings/0001628280-26-053128.md) | [(6.6) d](/filings/0001628280-25-052765.md) | [(18.9)](/filings/0001628280-26-006288.md) | [18.4](/filings/0001628280-26-031376.md) | [25.0](/filings/0001628280-26-053128.md) |
| Interest expense | $m | [18.7 d](/filings/0001628280-25-052765.md) | [19.8](/filings/0001628280-25-004522.md) | [20.4](/filings/0001628280-25-023206.md) | [18.8](/filings/0001628280-25-037827.md) | [17.5 d](/filings/0001628280-25-052765.md) | [18.8](/filings/0001628280-26-006288.md) | [20.2](/filings/0001628280-26-031376.md) | [19.4](/filings/0001628280-26-053128.md) | [14.8 d](/filings/0001628280-25-052765.md) | [19.3](/filings/0001628280-26-006288.md) | [17.9](/filings/0001628280-26-031376.md) | [16.7](/filings/0001628280-26-053128.md) |
| Income tax | $m | [3.4 d](/filings/0001628280-25-052765.md) | [1.2](/filings/0001628280-25-004522.md) | [11.0](/filings/0001628280-25-023206.md) | [13.5](/filings/0001628280-25-037827.md) | [(3.4) d](/filings/0001628280-25-052765.md) | [(2.6)](/filings/0001628280-26-006288.md) | [10.6](/filings/0001628280-26-031376.md) | [7.0](/filings/0001628280-26-053128.md) | [(16.8) d](/filings/0001628280-25-052765.md) | [(7.7)](/filings/0001628280-26-006288.md) | [3.9](/filings/0001628280-26-031376.md) | [5.7](/filings/0001628280-26-053128.md) |
| Net income | $m | [29.9](/filings/0001628280-23-040139.md) | [4.8](/filings/0001628280-25-037827.md) | [36.0](/filings/0001628280-25-037827.md) | [49.0](/filings/0001628280-25-037827.md) | [8.8 d](/filings/0001628280-25-052765.md) | [(2.1)](/filings/0001628280-26-053128.md) | [29.0](/filings/0001628280-26-053128.md) | [29.1](/filings/0001628280-26-053128.md) | [(30.6) d](/filings/0001628280-25-052765.md) | [(65.7)](/filings/0001628280-26-053128.md) | [(10.6)](/filings/0001628280-26-053128.md) | [13.7](/filings/0001628280-26-053128.md) |
| Diluted EPS | $ per share | [0.58](/filings/0001628280-23-040139.md) | [0.09](/filings/0001628280-25-004522.md) | [0.72](/filings/0001628280-25-023206.md) | [0.98](/filings/0001628280-25-037827.md) | not reported | [(0.04)](/filings/0001628280-26-006288.md) | [0.60](/filings/0001628280-26-031376.md) | [0.62](/filings/0001628280-26-053128.md) | not reported | [(1.41)](/filings/0001628280-26-006288.md) | [(0.22)](/filings/0001628280-26-031376.md) | [0.29](/filings/0001628280-26-053128.md) |
| Basic EPS | $ per share | [0.59](/filings/0001628280-23-040139.md) | [0.10](/filings/0001628280-25-004522.md) | [0.72](/filings/0001628280-25-023206.md) | [0.99](/filings/0001628280-25-037827.md) | not reported | [(0.04)](/filings/0001628280-26-006288.md) | [0.60](/filings/0001628280-26-031376.md) | [0.62](/filings/0001628280-26-053128.md) | not reported | [(1.41)](/filings/0001628280-26-006288.md) | [(0.23)](/filings/0001628280-26-031376.md) | [0.30](/filings/0001628280-26-053128.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [216](/filings/0001628280-24-047916.md) | not reported | not reported | not reported | [209](/filings/0001628280-24-047916.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [962](/filings/0001628280-24-047916.md) | [1,006](/filings/0001628280-24-003698.md) | [995](/filings/0001628280-24-021700.md) | [959](/filings/0001628280-24-035205.md) | [936](/filings/0001628280-25-052765.md) | [945](/filings/0001628280-25-004522.md) | [1,012](/filings/0001628280-25-023206.md) | [1,005](/filings/0001628280-25-037827.md) | [996](/filings/0001628280-26-053128.md) | [1,057](/filings/0001628280-26-006288.md) | [1,110](/filings/0001628280-26-031376.md) | [1,112](/filings/0001628280-26-053128.md) |
| Total assets | $m | [3,741](/filings/0001628280-24-047916.md) | [3,787](/filings/0001628280-24-003698.md) | [3,756](/filings/0001628280-24-021700.md) | [3,708](/filings/0001628280-24-035205.md) | [3,731](/filings/0001628280-25-052765.md) | [3,702](/filings/0001628280-25-004522.md) | [3,773](/filings/0001628280-25-023206.md) | [3,793](/filings/0001628280-25-037827.md) | [3,756](/filings/0001628280-26-053128.md) | [3,768](/filings/0001628280-26-006288.md) | [3,533](/filings/0001628280-26-031376.md) | [3,535](/filings/0001628280-26-053128.md) |
| Current liabilities | $m | [523](/filings/0001628280-24-047916.md) | [468](/filings/0001628280-24-003698.md) | [542](/filings/0001628280-24-021700.md) | [535](/filings/0001628280-24-035205.md) | [564](/filings/0001628280-25-052765.md) | [459](/filings/0001628280-25-004522.md) | [536](/filings/0001628280-25-023206.md) | [567](/filings/0001628280-25-037827.md) | [566](/filings/0001628280-26-053128.md) | [498](/filings/0001628280-26-006288.md) | [614](/filings/0001628280-26-031376.md) | [604](/filings/0001628280-26-053128.md) |
| Total liabilities | $m | [2,200](/filings/0001628280-24-047916.md) | [2,241](/filings/0001628280-24-003698.md) | [2,205](/filings/0001628280-24-021700.md) | [2,132](/filings/0001628280-24-035205.md) | [2,147](/filings/0001628280-25-052765.md) | [2,201](/filings/0001628280-25-004522.md) | [2,259](/filings/0001628280-25-023206.md) | [2,225](/filings/0001628280-25-037827.md) | [2,203](/filings/0001628280-26-053128.md) | [2,282](/filings/0001628280-26-006288.md) | [2,085](/filings/0001628280-26-031376.md) | [2,076](/filings/0001628280-26-053128.md) |
| Long-term debt | $m | [1,361](/filings/0001628280-24-047916.md) | [1,452](/filings/0001628280-24-003698.md) | [1,351](/filings/0001628280-24-021700.md) | [1,290](/filings/0001628280-24-035205.md) | [1,275](/filings/0001628280-25-052765.md) | [1,441](/filings/0001628280-25-004522.md) | [1,433](/filings/0001628280-25-023206.md) | [1,373](/filings/0001628280-25-037827.md) | [1,383](/filings/0001628280-26-053128.md) | [1,521](/filings/0001628280-26-006288.md) | [1,244](/filings/0001628280-26-031376.md) | [1,245](/filings/0001628280-26-053128.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,541](/filings/0001628280-25-052765.md) | [1,546](/filings/0001628280-25-037827.md) | [1,551](/filings/0001628280-25-037827.md) | [1,577](/filings/0001628280-25-037827.md) | [1,584](/filings/0001628280-26-053128.md) | [1,501](/filings/0001628280-26-053128.md) | [1,514](/filings/0001628280-26-053128.md) | [1,568](/filings/0001628280-26-053128.md) | [1,553](/filings/0001628280-26-053128.md) | [1,486](/filings/0001628280-26-053128.md) | [1,448](/filings/0001628280-26-053128.md) | [1,460](/filings/0001628280-26-053128.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(384) d](/filings/0001628280-25-052765.md) | [(72.9)](/filings/0001628280-25-004522.md) | [129 d](/filings/0001628280-25-023206.md) | [101 d](/filings/0001628280-25-037827.md) | [(388) d](/filings/0001628280-25-052765.md) | [(116)](/filings/0001628280-26-006288.md) | [45.1 d](/filings/0001628280-26-031376.md) | [115 d](/filings/0001628280-26-053128.md) | [74.1 d](/filings/0001628280-25-052765.md) | [(126)](/filings/0001628280-26-006288.md) | [54.3 d](/filings/0001628280-26-031376.md) | [119 d](/filings/0001628280-26-053128.md) |
| Capital expenditure | $m | [18.4 d](/filings/0001628280-25-052765.md) | [6.5](/filings/0001628280-25-004522.md) | [11.5 d](/filings/0001628280-25-023206.md) | [12.6 d](/filings/0001628280-25-037827.md) | [25.9 d](/filings/0001628280-25-052765.md) | [16.8](/filings/0001628280-26-006288.md) | [17.1 d](/filings/0001628280-26-031376.md) | [15.5 d](/filings/0001628280-26-053128.md) | [27.6 d](/filings/0001628280-25-052765.md) | [11.6](/filings/0001628280-26-006288.md) | [14.0 d](/filings/0001628280-26-031376.md) | [15.6 d](/filings/0001628280-26-053128.md) |
| Dividends paid | $m | [7.7 d](/filings/0001628280-25-052765.md) | [7.6](/filings/0001628280-25-004522.md) | [8.2 d](/filings/0001628280-25-023206.md) | [7.5 d](/filings/0001628280-25-037827.md) | [7.4 d](/filings/0001628280-25-052765.md) | [7.9](/filings/0001628280-26-006288.md) | [7.3 d](/filings/0001628280-26-031376.md) | [7.2 d](/filings/0001628280-26-053128.md) | [6.9 d](/filings/0001628280-25-052765.md) | [7.4](/filings/0001628280-26-006288.md) | [7.1 d](/filings/0001628280-26-031376.md) | [7.0 d](/filings/0001628280-26-053128.md) |
| Share repurchases | $m | [30.0 d](/filings/0001628280-25-052765.md) | [15.0](/filings/0001628280-25-004522.md) | [15.3 d](/filings/0001628280-25-023206.md) | [9.9 d](/filings/0001628280-25-037827.md) | [18.3 d](/filings/0001628280-25-052765.md) | [30.3](/filings/0001628280-26-006288.md) | [35.4 d](/filings/0001628280-26-031376.md) | [24.5 d](/filings/0001628280-26-053128.md) | [0.0 d](/filings/0001628280-25-052765.md) | [0.0](/filings/0001628280-26-006288.md) | [15.8 d](/filings/0001628280-26-031376.md) | [0.0 d](/filings/0001628280-26-053128.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.9](/filings/0001628280-24-003698.md) | [52.0](/filings/0001628280-24-021700.md) | [51.8](/filings/0001628280-24-035205.md) | [50.5](/filings/0001628280-25-004522.md) | [50.2](/filings/0001628280-25-023206.md) | [50.1](/filings/0001628280-25-037827.md) | [48.7](/filings/0001628280-26-006288.md) | [48.2](/filings/0001628280-26-031376.md) | [47.0](/filings/0001628280-26-053128.md) | [46.6](/filings/0001628280-26-006288.md) | [46.8](/filings/0001628280-26-031376.md) | [46.6](/filings/0001628280-26-053128.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 46,088,915 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053128.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.